Elevated CLR integrates two critical biological processes: C-reactive protein (CRP) elevation reflects IL-6-driven hepatic synthesis in response to tumor-associated inflammation (19), while lymphocytopenia indicates immunosuppression and reduced cytotoxic T-cell activity (20). This evidence concerns the gene CRP and neoplasm.